During this segment, Genevieve Kumapley, PharmD, BCOP, discusses the potential advantages and disadvantages of oral oncolytics and intravenous chemotherapies.
The use of oral oncolytics is becoming increasingly common in cancer treatment, notes Dr Kumapley; however, healthcare professionals should recognize that oral treatment options are associated with advantages and disadvantages. For instance, to patients in rural areas who live far from healthcare facilities, oral agents may offer the advantage of ease of access. However, unlike patients who receive intravenous chemotherapy in a facility under the care of healthcare professionals, patients treated with oral oncolytics take on more personal responsibility for their care. They are likely to have to manage adverse events on their own because of less face-to-face interaction with their healthcare professionals, she adds.
Dr Kumapley also discusses the factors that healthcare professionals consider when making decisions about whether to use oral oncolytic therapy or intravenous chemotherapy. Treatment guidelines, patient lifestyle factors, and patient access to treatment facilities are among the top considerations, she says.
In end-of-life care scenarios, additional considerations related to the appropriateness of oral oncolytic therapy include treatment costs, symptom management, and the patient’s cultural and spiritual beliefs. Given all these considerations, it is critical to include the multiple stakeholders involved in patient care when making treatment decisions, remarks Dr Kumapley.
Varied Access: The Pharmacogenetic Testing Coverage Divide
February 18th 2025On this episode of Managed Care Cast, we speak with the author of a study published in the February 2025 issue of The American Journal of Managed Care® to uncover significant differences in coverage decisions for pharmacogenetic tests across major US health insurers.
Listen
Closing the Gaps in Cardiac Care With Technology, Collaboration
March 12th 2025Cardiologists, primary care physicians, and value-based care leaders convened in Phoenix, Arizona, on November 12, 2024, to share case studies and insights on how to align cardiology with the principles of value-based care, including through the application of digital tools.
Read More